Clinical Reviews in Allergy & Immunology

, Volume 27, Issue 2, pp 147–158

Fatalities following allergen immunotherapy

  • Andrea T. Borchers
  • Carl L. Keen
  • M. Eric Gershwin
The Clinical Practice of Allergy

Abstract

Allergen immunotherapy has been in use for nearly 100 yr and has become an important method of reducing allergic symptoms in select patients with allergic rhinitis, asthma, and insect venom hypersensitivity. Unfortunately, immunotherapy has been associated with anaphylaxis and death. Although the relative risk of severe reactions to immunotherapy is low, the number of such reactions has increased since the introduction of standardized and more potent extracts. There are a number of risk factors associated with such severe anaphylactic reactions. Such risk factors include errors in dosage, failure to reduce the dosage after a longer than scheduled interval, administration of the wrong extract, inadvertent intravenous administration, failure to postpone injection because of infection or asthma exacerbation, failure to observe patients for appropriate length of time, failure to adhere to guidelines for established contraindications, concurrent use of β-adrenergic blocking agents, uses of mixtures of allergens, immunotherapy during the active allergy season, and types of allergens. In this review, we focus on these and other risk factors in attempts to reduce the risk of anaphylaxis following allergen immunotherapy.

Index Entries

Allergen immunotherapy immunotherapy fatalities systemic reactions to immunotherapy anaphylaxis asthma rhinitis insect sting hypersensitivity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lamson, R. W. (1924), JAMA 82, 1090–1098.Google Scholar
  2. 2.
    Lamson, R. W. (1929) JAMA 93, 1775–1778.Google Scholar
  3. 3.
    Lockey, R. F., Nicoara-Kasti, G. L., Theodoropoulos, D. S., and Bukantz, S. C. (2001), Ann. Allergy Asthma Immunol. 87(1 Suppl 1), 47–55.PubMedGoogle Scholar
  4. 4.
    Lockey, R. F., Benedict, L. M., Turkeltaub, P. C., and Bukantz, S. C. (1987), J. Allergy Clin. Immunol. 79, 660–677.PubMedCrossRefGoogle Scholar
  5. 5.
    Reid, M. J., Lockey, R. F., Turkeltaub P. C., and Platts-Mills, T. A. (1993), J. Allergy Clin. Immunol. 92, 6–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Reid, M. J., Lockey, R. F., Turkeltaub, P., Platts-Mills, T. A. E., and Lehrer, S. B. (1992), J. Allergy Clin. Immunol. 89, 350.CrossRefGoogle Scholar
  7. 7.
    Kordash, T., and Miller, J. (1997), J. Allergy Clin. Immunol. 99, S67.Google Scholar
  8. 8.
    American College of Allergy Asthma and Immunology. Fact Sheet: Efficacy and Safety of Immunotherapy. http://allergy.mcg.edu/patients/ factsheet.html.Google Scholar
  9. 9.
    Terr A. I., and Bloch D. A. (1996), Ann. Allergy Asthma Immunol. 76, 273–281.PubMedGoogle Scholar
  10. 10.
    Committee on Safety of Medicines. (1986), BMJ 293, 948.CrossRefGoogle Scholar
  11. 11.
    Lüderitz-Püchel, U., May, S., and Haustein, D. (1996), Munch. Med. Wochenschr. 138, 129–132.Google Scholar
  12. 12.
    Executive Committee AAAI. (1990), J. Allergy Clin. Immunol. 85, 526–527.CrossRefGoogle Scholar
  13. 13.
    Toubi, E., Kessel, A., Blant, A., and Golan, T. D. (1999), Allergy 54, 617–620.PubMedCrossRefGoogle Scholar
  14. 14.
    Mellerup, M. T., Hahn, G. W., Poulsen, L. K., and Malling, H.-J. (2000), Clin. Exp. Allergy 30, 1423–1429.PubMedCrossRefGoogle Scholar
  15. 15.
    Nettis, E., Giordano, D., Pannofino, A., Ferrannini, A., and Tursi, A. (2002), Clin. Exp. Allergy 32, 1745–1749.PubMedCrossRefGoogle Scholar
  16. 16.
    Tabar, A. I., García, B. E., Rodríguez, A., Olaguibel, J. M., Muro, M. D., and Quirce, S. (1993), Allergy 48, 450–453.PubMedCrossRefGoogle Scholar
  17. 17.
    Moreno, C., Cuesta-Herranz, J., Fernández-Távora, L., and Alvarez-Cuesta, E. (2004), Clin. Exp. Allergy 34, 527–531.PubMedCrossRefGoogle Scholar
  18. 18.
    Gastaminza, G., Algorta, J., Audicana, M., Etxenaugusia, M., Fernández, E., and Muñoz, D. (2003), Clin. Exp. Allergy 33, 470–474.PubMedCrossRefGoogle Scholar
  19. 19.
    Mosbech, H., and Müller, U. (2000), Allergy 55, 1005–1010.PubMedCrossRefGoogle Scholar
  20. 20.
    Bousquet, J., Hejjaoui, A., Dhivert, H., Clauzel, A. M., and Michel, F. B. (1989), J. Allergy Clin. Immunol. 83, 797–802.PubMedCrossRefGoogle Scholar
  21. 21.
    Malling, H.-J., and Weeke, B., eds. (1993), Allergy 48(14 Suppl), 7–35.Google Scholar
  22. 22.
    Thoracic Society of Australia and New Zealand and the Australasian Society of Clinical Immunology and Allergy. (1997), Med. J. Aust. 167, 540–544.Google Scholar
  23. 23.
    Li, J. T., Lockey, R. F., Bernstein, I. L., Portnoy, J. M., Nicklas, R. A. (2003), Ann. Allergy Asthma Immunol. 90, 1–40.CrossRefGoogle Scholar
  24. 24.
    Lockey, R. F., Turkeltaub, P. C., Olive, E. S., Hubbard, J. M., Baird-Warren, I. A., and Bukantz, S. C. (1990), J. Allergy Clin. Immunol. 86, 775–780.PubMedCrossRefGoogle Scholar
  25. 25.
    Greenberg, M. A., Kaufman, C. R., Gonzalez, G. E., Rosenblatt, C. D., Smith, L. J., and Summers, R. J. J. (1986), Allergy Clin. Immunol. 77, 865–870.CrossRefGoogle Scholar
  26. 26.
    Businco, L., Zannino, L., Cantani, A., Corrias, A., Fiocchi, A., and La Rosa, M. (1995), Pediatr. Allergy Immunol. 6, 44–47.PubMedCrossRefGoogle Scholar
  27. 27.
    Lin, M. S., Tanner, E., Lynn, J., and Friday, G. A., Jr. (1993), Ann. Allergy 71, 557–562.PubMedGoogle Scholar
  28. 28.
    Müller, U., and Mosbech, H. (1993), Allergy 48(14 Suppl), 36–46.Google Scholar
  29. 29.
    Bousquet, J., Lockey, R. F., and Malling, H.-J. (1998), Allergy 53(Suppl 44), 1–42.Google Scholar
  30. 30.
    Hepner, M. J., Ownby, D. R., Anderson, J. A., Rowe, M. S., Sears-Ewald, D., and Brown, E. B. (1990), J. Allergy Clin. Immunol. 86, 407–411.PubMedCrossRefGoogle Scholar
  31. 31.
    Bousquet, J., Lockey, R., Malling, H.-J., and The WHO panel members. (1998), J. Allergy Clin. Immunol. 102, 558–562.PubMedCrossRefGoogle Scholar
  32. 32.
    Van Arsdel, P. P., Jr., and Sherman, W. B. (1957), J. Allergy 28, 251–261.CrossRefGoogle Scholar
  33. 33.
    Winther, L., Malling, H.-J., and Mosbech, H. (2000), Allergy 55, 827–835.PubMedCrossRefGoogle Scholar
  34. 34.
    Birnbaum, J., Ramadour, M., Magnan, A., and Vervloet, D. (2003), Clin. Exp. Allergy 33, 58–64.PubMedCrossRefGoogle Scholar
  35. 35.
    Practice parameters for allergen immunotherapy. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. (1996), J. Allergy Clin. Immunol. 98, 1001–1011.Google Scholar
  36. 36.
    Antonicelli, L., Bilò, M. B., and Bonifazi, F. (2002), Curr. Opin. Allergy Clin. Immunol. 2, 341–346.PubMedCrossRefGoogle Scholar
  37. 37.
    Brown, S. G., and Heddle, R. J. (2003), Curr. Opin. Allergy Clin. Immunol. 3, 511–516.PubMedCrossRefGoogle Scholar
  38. 38.
    Brown, S. G., Franks, R. W., Baldo, B. A., and Heddle, R. J. (2003), J. Allergy Clin. Immunol. 111, 187–192.PubMedCrossRefGoogle Scholar
  39. 39.
    Brown, S. G. A., Wiese, M. D., Blackman, K. E., and Heddle, R. J. (2003), Lancet 361, 1001–1006.PubMedCrossRefGoogle Scholar
  40. 40.
    Harvey, P., Sperber, S., Kette, F., Heddle, R. J., and Roberts-Thomson, P. J. (1984), Med. J. Aust. 140, 209–211.PubMedGoogle Scholar
  41. 41.
    Abramson, M. J., Puy, R. M., and Weiner, J. M. (2003), Cochrane Database Syst. Rev. 2, 2004.Google Scholar
  42. 42.
    Wilson, D. R., Torres Lima, M., and Durham, S. R. (2003), Cochrane Database Syst. Rev. 2, 2004.Google Scholar

Copyright information

© Humana Press Inc. 2004

Authors and Affiliations

  • Andrea T. Borchers
    • 1
  • Carl L. Keen
    • 1
  • M. Eric Gershwin
    • 1
  1. 1.Division of Rheumatology, Allergy and Clinical ImmunologyUniversity of California at Davis School of MedicineDavis

Personalised recommendations